Physician profile
Daniel Adamovsky
NPI 1174511521
$8,022.13
in general payments reported to CMS, 2019-2025
44 companies · $1,441 in 2025
The $1,441 reported for 2025 was more than what 77% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $630 · 2020: $460 · 2021: $668 · 2022: $1,653 · 2023: $1,443 · 2024: $1,728 · 2025: $1,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,250 · Travel and Lodging: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,249.87 |
| Travel and Lodging | $1,362.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $2,711.73 | 2020-2025 | |
| Kerecis Limited | $1,356.19 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Stryker Corporation | $700.78 | 2019-2025 | Viaflow, Darco, N/A |
| Zyla Life Sciences, INC. | $339.88 | 2019-2020 | |
| Organogenesis INC. | $338.19 | 2019-2022 | |
| Koya Medical, INC. | $302.23 | 2023-2024 | Dayspring, Koya Medical |
| Nevro Corp. | $261.71 | 2022-2024 | Senza |
| Paratek Pharmaceuticals, INC. | $236.94 | 2020-2025 | Nuzyra |
| Arthrex, INC. | $200.95 | 2025 | |
| Novastep INC. | $195.70 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $123.27 | 2022-2023 | Seglentis |
| Vaporox, INC. | $101.79 | 2023-2024 | Vht-200 Wound Treatment System |
| Smith+Nephew, INC. | $95.67 | 2019-2023 | Grafix Pl |
| Integra Lifesciences Corporation | $93.22 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $80.88 | 2024 | Novosorb Btm |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $76.18 | 2019-2022 | |
| Wright Medical Technology, INC. | $73.73 | 2019 | |
| Paragon 28, INC. | $61.93 | 2021-2023 | Ankle Fracture, Phantom Metatarsal Shortening |
| Ani Pharmaceuticals, INC. | $57.72 | 2022-2023 | Purified Cortrophin Gel |
| Horizon Therapeutics Plc | $51.39 | 2021 | |
| Globus Medical, INC. | $47.76 | 2025 | Senza |
| Treace Medical Concepts, INC. | $46.30 | 2023 | |
| Epsfl, LLC | $43.52 | 2023 | |
| Sandoz INC. | $43.23 | 2019 | |
| Arteriocyte Medical Systems, INC. | $31.14 | 2019-2022 | |
| Bioventus LLC | $28.32 | 2019-2021 | |
| Medline Industries Lp | $26.69 | 2022 | |
| Xtant Medical INC | $26.57 | 2021 | |
| Averitas Pharma INC. | $23.02 | 2025 | Qutenza |
| Tactile Systems Technology INC | $21.50 | 2022 | |
| Abbvie INC. | $21.26 | 2024 | |
| Arthrosurface Incorporated | $18.49 | 2020 | |
| Medtronic, INC. | $18.43 | 2023 | Intellis Adaptivestim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.82 | 2021 | |
| Cpm Medical Consultants, LLC | $16.95 | 2023 | Orbitum Staple System |
| Solventum Corporation | $16.77 | 2025 | Activ.A.C. |
| Lifenet Health | $16.71 | 2024 | Theragenesis Wound Matrix |
| Osiris Therapeutics INC. | $15.99 | 2019 | |
| Axogen | $15.78 | 2019 | |
| Cashflow Solutions, LLC | $15.37 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Orthofix Medical, INC. | $13.99 | 2019 | |
| Fidia Pharma USA INC. | $12.82 | 2023 | Hymovis, Triluron |
| Advanced Oxygen Therapy INC. | $12.53 | 2021 | |
| Misonix INC | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Adamovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.